Effectiveness of add‐on therapy with SGLT2 inhibitors or GLP‐1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study.

The study examines the effectiveness of add-on therapy with SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 1 diabetes using real-world data from the DPV registry. Results show improvements in HbA1c, systolic blood pressure, and cholesterol levels without increasing the risk of ketoacidosis or severe hypoglycemia. However, the clinical relevance of these improvements may be limited, and further research is needed to identify specific subgroups that may benefit from this therapy. The study highlights the need for larger, long-term studies to assess the efficacy of these treatments in type 1 diabetes. [Extracted from the article]